ARCHIVES

IND-Exempt Trials May Need Special Review, HCFA Says.

This article is from The Cancer Letter archive.

Vol. 26 No. 35 | September 29, 2000

Download PDF Visit The Full Archive

Related Articles

How a two-faced media covered cancer: Promoting research—and cigarettes

April 29, 2022

NCAB Supports NCI Director’s Call For Increase In Management Funds.

December 8, 2000

COMMIT Moving Into Implementation

July 15, 1988

NCAB Approves New Pancreatic Cancer Project, Hears Favorable Reports On Organ site Programs

November 29, 1974

Non-Caucasians At Higher Risk For Severe Breast Cancer Pain

December 28, 2007

NCI Director and Acting FDA Commissioner Andrew von Eschenbach Endorses Rep. E. Clay Shaw In Tour of Florida Congressman’s District. Von Eschenbach Praises Shaw’s “Leadership” In Seeking Funding For Research, Support of 2015 Goal.

February 3, 2006